Literature DB >> 2376011

Serum cytotoxicity to human and rat oligodendrocytes in culture.

T C Ruijs1, A Olivier, J P Antel.   

Abstract

Serum from multiple sclerosis (MS) patients can cause demyelination in rat CNS explant cultures and induce cytotoxicity to rat oligodendrocytes in culture. The interpretation of these findings for MS is complicated by the fact that injury to myelin and oligodendrocytes can also be induced with normal human serum. In this study, we confirmed that serum from MS patients and healthy control subjects can cause in vitro toxicity to rat oligodendrocytes, as established by a 51Cr release assay, but we did not detect toxicity to human cultured oligodendrocytes. Morphologic changes after 5-6 h incubation with the sera were also extensive in the rat oligodendrocyte cultures. No morphologic changes or changes in cell numbers could be detected in the human cultures upon examination by light microscopy and by immunofluorescent staining with anti-GalC antibody.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2376011     DOI: 10.1016/0006-8993(90)91013-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disorders.

Authors:  J Roddy; I Clark; B L Hazleman; D A Compston; N J Scolding
Journal:  J Neurol       Date:  1994-08       Impact factor: 4.849

2.  Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma.

Authors:  Tharusha Jayasena; Anne Poljak; Nady Braidy; George Smythe; Mark Raftery; Mark Hill; Henry Brodaty; Julian Trollor; Nicole Kochan; Perminder Sachdev
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

3.  Body fluids from the rat exposed to chlorpyrifos induce cytotoxicity against the corresponding tissue-derived cells in vitro.

Authors:  Yu-Jie Liang; Ding-Xin Long; Ming-Yuan Xu; Hui-Ping Wang; Ying-Jian Sun; Yi-Jun Wu
Journal:  BMC Pharmacol Toxicol       Date:  2021-10-20       Impact factor: 2.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.